Knight Therapeutics | GUD - EPS Earnings Per Share

Stock Price
7.69
Daily Change
0.24 3.22%
Monthly
24.03%
Yearly
35.15%
Q2 Forecast
7.26

Knight Therapeutics reported CAD-0.09 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2027Q1 Mar/2026 -0.01 0.04 May/07




Eps Change Date
Acasti Pharma USD -0.06 0.15 Sep/2025
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alaunos Therapeutics USD -0.53 0.08 Sep/2025
Aurora Cannabis CAD -0.64 0.36 Dec/2025
Avita Medical AUD -0.38 0 Dec/2025
Canopy Growth CAD -0.05 0.03 Dec/2025
Cronos Group USD 0.02 0.05 Dec/2025
Dianthus Therapeutics USD -1.43 0.46 Dec/2025
Ionis Pharmaceuticals USD -1.41 0.61 Dec/2025
IQVIA Holdings USD 3.42 0.42 Dec/2025
Knight Therapeutics CAD -0.09 0.12 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Omeros USD -1.12 0.37 Jun/2024
Organigram Holdings CAD -0.16 0.02 Dec/2025
Organon & Co USD 0.63 0.38 Dec/2025
Revvity USD 1.7 0.52 Dec/2025
Tectonic Therapeutic USD -1.03 0.01 Dec/2025
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.57 0.1 Dec/2025
Xeris Pharmaceuticals USD 0.05 0.05 Dec/2025